_id
69105283ccc777a4e85d54cb
Ticker
COCHW
Name
Envoy Medical Inc.
Exchange
NASDAQ
Address
4875 White Bear Parkway, White Bear Lake, MN, United States, 55110
Country
USA
Sector
Industry
Currency
USD
Website
https://www.envoymedical.com
Description
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Last Close
0.04
Volume
11684
Current Price
0.046
Change
-0.0001
Last Updated
2026-01-02T11:46:00.697Z
Image
data:image/webp;base64,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
Ipo Date
2021-04-23T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
42000
Cost Of Revenue
203000
Gross Profit
-161000
Operating Expenses
5547000
Operating Income
-5708000
Interest Expense
471000
Pretax Income
-6482000
Net Income
-6482000
Eps
-0.3307145894317658
Dividends Per Share
0
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-5935000
Operating Margin
-13590.476190476189
Total Other Income Expense Net
-774000
Cash
3556000
Short Term Investments
-
Receivables
35000
Inventories
1639000
Total Current Assets
5757000
Property Plant Equipment
2034000
Total Assets
8181000
Payables
2681000
Short Term Debt
168000
Long Term Debt
-
Total Liabilities
15712000
Equity
-7531000
Bs_currency_symbol
USD
Depreciation
76000
Change In Working Capital
762000
Cash From Operations
-4331000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
2601000
Net Change In Cash
-1731000
Cf_currency_symbol
USD
PE
-
PB
-0.1197183869340061
ROE
86.07090691807197
ROA
-79.23236768121257
FCF
-4331000
Fcf Percent
-103.11904761904762
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
0
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
4.5
Net Net Investing Score
0
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
42000
Quarters > 0 > income Statement > cost Of Revenue
203000
Quarters > 0 > income Statement > gross Profit
-161000
Quarters > 0 > income Statement > operating Expenses
5547000
Quarters > 0 > income Statement > operating Income
-5708000
Quarters > 0 > income Statement > interest Expense
471000
Quarters > 0 > income Statement > pretax Income
-6482000
Quarters > 0 > income Statement > net Income
-6482000
Quarters > 0 > income Statement > eps
-0.3307145894317658
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
19599982
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-5935000
Quarters > 0 > income Statement > operating Margin
-13590.476190476189
Quarters > 0 > income Statement > total Other Income Expense Net
-774000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
3556000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
35000
Quarters > 0 > balance Sheet > inventories
1639000
Quarters > 0 > balance Sheet > total Current Assets
5757000
Quarters > 0 > balance Sheet > property Plant Equipment
2034000
Quarters > 0 > balance Sheet > total Assets
8181000
Quarters > 0 > balance Sheet > payables
2681000
Quarters > 0 > balance Sheet > short Term Debt
168000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
15712000
Quarters > 0 > balance Sheet > equity
-7531000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-6482000
Quarters > 0 > cash Flow > depreciation
76000
Quarters > 0 > cash Flow > change In Working Capital
762000
Quarters > 0 > cash Flow > cash From Operations
-4331000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
2601000
Quarters > 0 > cash Flow > net Change In Cash
-1731000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.3307145894317658
Quarters > 0 > ratios > PB
-0.1197183869340061
Quarters > 0 > ratios > ROE
86.07090691807197
Quarters > 0 > ratios > ROA
-79.23236768121257
Quarters > 0 > ratios > FCF
-4331000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-103.11904761904762
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
78000
Quarters > 1 > income Statement > cost Of Revenue
234000
Quarters > 1 > income Statement > gross Profit
-156000
Quarters > 1 > income Statement > operating Expenses
4914000
Quarters > 1 > income Statement > operating Income
-5070000
Quarters > 1 > income Statement > interest Expense
624000
Quarters > 1 > income Statement > pretax Income
-5690000
Quarters > 1 > income Statement > net Income
-5690000
Quarters > 1 > income Statement > eps
-0.29030638905688794
Quarters > 1 > income Statement > dividends Per Share
607000
Quarters > 1 > income Statement > shares Outstanding
19599982
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4981000
Quarters > 1 > income Statement > operating Margin
-6500
Quarters > 1 > income Statement > total Other Income Expense Net
-620000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
5287000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
63000
Quarters > 1 > balance Sheet > inventories
1587000
Quarters > 1 > balance Sheet > total Current Assets
7513000
Quarters > 1 > balance Sheet > property Plant Equipment
1964000
Quarters > 1 > balance Sheet > total Assets
9900000
Quarters > 1 > balance Sheet > payables
1619000
Quarters > 1 > balance Sheet > short Term Debt
198000
Quarters > 1 > balance Sheet > long Term Debt
27932000
Quarters > 1 > balance Sheet > total Liabilities
39759000
Quarters > 1 > balance Sheet > equity
-29859000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-5690000
Quarters > 1 > cash Flow > depreciation
85000
Quarters > 1 > cash Flow > change In Working Capital
77000
Quarters > 1 > cash Flow > cash From Operations
-4460000
Quarters > 1 > cash Flow > capital Expenditures
1000
Quarters > 1 > cash Flow > cash From Investing
-1000
Quarters > 1 > cash Flow > cash From Financing
4438000
Quarters > 1 > cash Flow > net Change In Cash
-25000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.29030638905688794
Quarters > 1 > ratios > PB
-0.030195223282762317
Quarters > 1 > ratios > ROE
19.056230952141735
Quarters > 1 > ratios > ROA
-57.47474747474748
Quarters > 1 > ratios > FCF
-4461000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-57.19230769230769
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
46000
Quarters > 2 > income Statement > cost Of Revenue
226000
Quarters > 2 > income Statement > gross Profit
-180000
Quarters > 2 > income Statement > operating Expenses
4927000
Quarters > 2 > income Statement > operating Income
-5107000
Quarters > 2 > income Statement > interest Expense
495000
Quarters > 2 > income Statement > pretax Income
-4998000
Quarters > 2 > income Statement > net Income
-4998000
Quarters > 2 > income Statement > eps
-0.2343508229005486
Quarters > 2 > income Statement > dividends Per Share
1213000
Quarters > 2 > income Statement > shares Outstanding
21327000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-4442000
Quarters > 2 > income Statement > operating Margin
-11102.173913043478
Quarters > 2 > income Statement > total Other Income Expense Net
109000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
5312000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
42000
Quarters > 2 > balance Sheet > inventories
1657000
Quarters > 2 > balance Sheet > total Current Assets
8311999
Quarters > 2 > balance Sheet > property Plant Equipment
2073000
Quarters > 2 > balance Sheet > total Assets
10385000
Quarters > 2 > balance Sheet > payables
1662000
Quarters > 2 > balance Sheet > short Term Debt
145000
Quarters > 2 > balance Sheet > long Term Debt
23106000
Quarters > 2 > balance Sheet > total Liabilities
34609000
Quarters > 2 > balance Sheet > equity
-24224000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-4998000
Quarters > 2 > cash Flow > depreciation
61000
Quarters > 2 > cash Flow > change In Working Capital
922000
Quarters > 2 > cash Flow > cash From Operations
-3725000
Quarters > 2 > cash Flow > capital Expenditures
6000
Quarters > 2 > cash Flow > cash From Investing
-6000
Quarters > 2 > cash Flow > cash From Financing
3554000
Quarters > 2 > cash Flow > net Change In Cash
-171000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.2343508229005486
Quarters > 2 > ratios > PB
-0.04049876155878468
Quarters > 2 > ratios > ROE
20.63243064729194
Quarters > 2 > ratios > ROA
-48.12710640346654
Quarters > 2 > ratios > FCF
-3731000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-81.1086956521739
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
42000
Quarters > 3 > income Statement > cost Of Revenue
157000
Quarters > 3 > income Statement > gross Profit
-115000
Quarters > 3 > income Statement > operating Expenses
4409000
Quarters > 3 > income Statement > operating Income
-4524000
Quarters > 3 > income Statement > interest Expense
384000
Quarters > 3 > income Statement > pretax Income
-4618000
Quarters > 3 > income Statement > net Income
-4618000
Quarters > 3 > income Statement > eps
-0.2165330332442444
Quarters > 3 > income Statement > dividends Per Share
614000
Quarters > 3 > income Statement > shares Outstanding
21327000
Quarters > 3 > income Statement > income Tax Expense
9276
Quarters > 3 > income Statement > EBITDA
-4186000
Quarters > 3 > income Statement > operating Margin
-10771.42857142857
Quarters > 3 > income Statement > total Other Income Expense Net
-94000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
5483000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
818000
Quarters > 3 > balance Sheet > inventories
1708000
Quarters > 3 > balance Sheet > total Current Assets
9384000
Quarters > 3 > balance Sheet > property Plant Equipment
2154000
Quarters > 3 > balance Sheet > total Assets
11538000
Quarters > 3 > balance Sheet > payables
1652000
Quarters > 3 > balance Sheet > short Term Debt
143000
Quarters > 3 > balance Sheet > long Term Debt
18716000
Quarters > 3 > balance Sheet > total Liabilities
30380000
Quarters > 3 > balance Sheet > equity
-18842000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-6275000
Quarters > 3 > cash Flow > depreciation
48000
Quarters > 3 > cash Flow > change In Working Capital
-1010000
Quarters > 3 > cash Flow > cash From Operations
-4388000
Quarters > 3 > cash Flow > capital Expenditures
534000
Quarters > 3 > cash Flow > cash From Investing
534000
Quarters > 3 > cash Flow > cash From Financing
4914000
Quarters > 3 > cash Flow > net Change In Cash
1059000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.2165330332442444
Quarters > 3 > ratios > PB
-0.05206676573612143
Quarters > 3 > ratios > ROE
24.50907546969536
Quarters > 3 > ratios > ROA
-40.02426763737216
Quarters > 3 > ratios > FCF
-4922000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-117.19047619047619
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
225000
Annuals > 0 > income Statement > cost Of Revenue
742000
Annuals > 0 > income Statement > gross Profit
-517000
Annuals > 0 > income Statement > operating Expenses
18739000
Annuals > 0 > income Statement > operating Income
-19256000
Annuals > 0 > income Statement > interest Expense
816000
Annuals > 0 > income Statement > pretax Income
-20795000
Annuals > 0 > income Statement > net Income
-20795000
Annuals > 0 > income Statement > eps
-1.1067056945183609
Annuals > 0 > income Statement > dividends Per Share
2447000
Annuals > 0 > income Statement > shares Outstanding
18790000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-19806000
Annuals > 0 > income Statement > operating Margin
-8558.222222222223
Annuals > 0 > income Statement > total Other Income Expense Net
-1539000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
5483000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
818000
Annuals > 0 > balance Sheet > inventories
1708000
Annuals > 0 > balance Sheet > total Current Assets
9384000
Annuals > 0 > balance Sheet > property Plant Equipment
2154000
Annuals > 0 > balance Sheet > total Assets
11538000
Annuals > 0 > balance Sheet > payables
1652000
Annuals > 0 > balance Sheet > short Term Debt
143000
Annuals > 0 > balance Sheet > long Term Debt
18716000
Annuals > 0 > balance Sheet > total Liabilities
30380000
Annuals > 0 > balance Sheet > equity
-18842000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-22452000
Annuals > 0 > cash Flow > depreciation
173000
Annuals > 0 > cash Flow > change In Working Capital
-638000
Annuals > 0 > cash Flow > cash From Operations
-17949000
Annuals > 0 > cash Flow > capital Expenditures
980000
Annuals > 0 > cash Flow > cash From Investing
-980000
Annuals > 0 > cash Flow > cash From Financing
20198000
Annuals > 0 > cash Flow > net Change In Cash
1265000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.1067056945183609
Annuals > 0 > ratios > PB
-0.038792644092983754
Annuals > 0 > ratios > ROE
110.36514170470227
Annuals > 0 > ratios > ROA
-180.23054255503556
Annuals > 0 > ratios > FCF
-18929000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-84.1288888888889
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
316000
Annuals > 1 > income Statement > cost Of Revenue
789000
Annuals > 1 > income Statement > gross Profit
-473000
Annuals > 1 > income Statement > operating Expenses
17886000
Annuals > 1 > income Statement > operating Income
-18359000
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-29922000
Annuals > 1 > income Statement > net Income
-29922000
Annuals > 1 > income Statement > eps
-2.3836533099657453
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
12553000
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-29789000
Annuals > 1 > income Statement > operating Margin
-5809.810126582279
Annuals > 1 > income Statement > total Other Income Expense Net
-11563000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
4218000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
70000
Annuals > 1 > balance Sheet > inventories
1404000
Annuals > 1 > balance Sheet > total Current Assets
7456000
Annuals > 1 > balance Sheet > property Plant Equipment
815000
Annuals > 1 > balance Sheet > total Assets
8271000
Annuals > 1 > balance Sheet > payables
1554000
Annuals > 1 > balance Sheet > short Term Debt
158000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
10047000
Annuals > 1 > balance Sheet > equity
-1776000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-29922000
Annuals > 1 > cash Flow > depreciation
133000
Annuals > 1 > cash Flow > change In Working Capital
-983000
Annuals > 1 > cash Flow > cash From Operations
-17091000
Annuals > 1 > cash Flow > capital Expenditures
153000
Annuals > 1 > cash Flow > cash From Investing
-153000
Annuals > 1 > cash Flow > cash From Financing
21282000
Annuals > 1 > cash Flow > net Change In Cash
4035000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.3836533099657453
Annuals > 1 > ratios > PB
-0.2749502815315315
Annuals > 1 > ratios > ROE
1684.7972972972973
Annuals > 1 > ratios > ROA
-361.77003989844036
Annuals > 1 > ratios > FCF
-17244000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-54.56962025316456
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
237000
Annuals > 2 > income Statement > cost Of Revenue
498000
Annuals > 2 > income Statement > gross Profit
-261000
Annuals > 2 > income Statement > operating Expenses
8445000
Annuals > 2 > income Statement > operating Income
-8706000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-15923000
Annuals > 2 > income Statement > net Income
-15923000
Annuals > 2 > income Statement > eps
-1.568150482568446
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
10154000
Annuals > 2 > income Statement > income Tax Expense
-153000
Annuals > 2 > income Statement > EBITDA
-8631000
Annuals > 2 > income Statement > operating Margin
-3673.4177215189875
Annuals > 2 > income Statement > total Other Income Expense Net
-7217000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
183000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
41000
Annuals > 2 > balance Sheet > inventories
1295000
Annuals > 2 > balance Sheet > total Current Assets
1648000
Annuals > 2 > balance Sheet > property Plant Equipment
908000
Annuals > 2 > balance Sheet > total Assets
2556000
Annuals > 2 > balance Sheet > payables
1003000
Annuals > 2 > balance Sheet > short Term Debt
573000
Annuals > 2 > balance Sheet > long Term Debt
33397000
Annuals > 2 > balance Sheet > total Liabilities
38751000
Annuals > 2 > balance Sheet > equity
-36195000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-15923000
Annuals > 2 > cash Flow > depreciation
75000
Annuals > 2 > cash Flow > change In Working Capital
-160000
Annuals > 2 > cash Flow > cash From Operations
-8805000
Annuals > 2 > cash Flow > capital Expenditures
218000
Annuals > 2 > cash Flow > cash From Investing
-218000
Annuals > 2 > cash Flow > cash From Financing
8092000
Annuals > 2 > cash Flow > net Change In Cash
33155
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.568150482568446
Annuals > 2 > ratios > PB
-0.010912849841138278
Annuals > 2 > ratios > ROE
43.99226412487913
Annuals > 2 > ratios > ROA
-622.9655712050079
Annuals > 2 > ratios > FCF
-9023000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-38.07172995780591
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
310000
Annuals > 3 > income Statement > cost Of Revenue
769000
Annuals > 3 > income Statement > gross Profit
-459000
Annuals > 3 > income Statement > operating Expenses
6412000
Annuals > 3 > income Statement > operating Income
-6871000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-8675000
Annuals > 3 > income Statement > net Income
-8675000
Annuals > 3 > income Statement > eps
-0.8543431160133937
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
10154000
Annuals > 3 > income Statement > income Tax Expense
-166000
Annuals > 3 > income Statement > EBITDA
-6800000
Annuals > 3 > income Statement > operating Margin
-2216.451612903226
Annuals > 3 > income Statement > total Other Income Expense Net
-1804000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1121000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
88000
Annuals > 3 > balance Sheet > inventories
1060000
Annuals > 3 > balance Sheet > total Current Assets
2436000
Annuals > 3 > balance Sheet > property Plant Equipment
188000
Annuals > 3 > balance Sheet > total Assets
2624000
Annuals > 3 > balance Sheet > payables
661000
Annuals > 3 > balance Sheet > short Term Debt
460000
Annuals > 3 > balance Sheet > long Term Debt
23477000
Annuals > 3 > balance Sheet > total Liabilities
47584000
Annuals > 3 > balance Sheet > equity
-44960000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-8675000
Annuals > 3 > cash Flow > depreciation
71000
Annuals > 3 > cash Flow > change In Working Capital
-82000
Annuals > 3 > cash Flow > cash From Operations
-6936000
Annuals > 3 > cash Flow > capital Expenditures
125000
Annuals > 3 > cash Flow > cash From Investing
-125000
Annuals > 3 > cash Flow > cash From Financing
8058000
Annuals > 3 > cash Flow > net Change In Cash
987000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.8543431160133937
Annuals > 3 > ratios > PB
-0.008785378113879003
Annuals > 3 > ratios > ROE
19.294928825622776
Annuals > 3 > ratios > ROA
-330.6021341463415
Annuals > 3 > ratios > FCF
-7061000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-22.77741935483871
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.3307145894317658
Valuation > metrics > PB
-0.1197183869340061
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
86.07090691807197
Profitability > metrics > ROA
-112.59336459961786
Profitability > metrics > Net Margin
-154.33333333333334
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-12.118895966029724
Risk > final Score
-18
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.020709020709021
Liquidity > metrics > Quick Ratio
1.4454194454194453
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
38
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-2
Prev Risks > 1
-11
Prev Risks > 2
-17
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:38:16.828Z
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AValuation Update: What’s the profit margin of Interactive Strength Inc - Market Trend Report & Stock Timing and Entry Methods baoquankhu1.vn
Read more →Highs Report: Is ACMR stock trending bullish - Bull Run & Safe Capital Allocation Plans baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Envoy Medical Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.